Skip to main content
logo
Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
26.76
-0.29 (-1.07%)
Apr 9, 2026, 4:00 PM EDT - Market closed

Sutro Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
102.4862.04153.7367.7761.88
Revenue Growth (YoY)
65.18%-59.64%126.84%9.52%44.84%
Gross Profit
102.4862.04153.7367.7761.88
Selling, General & Admin
41.0248.4562.5859.5456
Research & Development
166.42252.04180.43137.17104.4
Other Operating Expenses
53.42----
Total Operating Expenses
260.85300.5243.01196.72160.4
Operating Income
-158.37-238.45-89.28-128.94-98.52
Interest Income
9.2518.6414.513.460.58
Interest Expense
-38.21-31.07-12.57--
Other Non-Operating Income (Expense)
-3.8625.78-1.268.78-7.59
Total Non-Operating Income (Expense)
-32.8113.360.6812.24-7.01
Pretax Income
-191.18-225.1-88.6-116.7-105.54
Provision for Income Taxes
-0.092.3618.192.5-
Net Income
-191.09-227.46-106.79-119.2-105.54
Net Income to Common
-191.09-227.46-106.79-119.2-105.54
Shares Outstanding (Basic)
88655
Shares Outstanding (Diluted)
88655
Shares Change (YoY)
9.84%28.59%18.57%10.02%41.59%
EPS (Basic)
-22.49-29.40-17.80-23.50-22.90
EPS (Diluted)
-22.49-29.40-17.80-23.50-22.90
Shares Outstanding
8.588.316.15.754.63
Free Cash Flow
-178.93-194.64-115.93-4.31-97
Free Cash Flow Per Share
-21.06-25.16-19.27-0.85-21.03
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-154.53%-384.33%-58.07%-190.26%-159.22%
Profit Margin
-186.45%-366.62%-69.47%-175.89%-170.55%
FCF Margin
-174.59%-313.72%-75.41%-6.36%-156.76%
EBITDA
-151.04-231.24-82.46-123.25-93.68
EBITDA Margin
-147.38%-372.70%-53.64%-181.86%-151.39%
EBIT
-158.37-238.45-89.28-128.94-98.52
EBIT Margin
-154.53%-384.33%-58.07%-190.26%-159.22%
Effective Tax Rate
0.05%-1.05%-20.53%-2.14%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q